iSERA Lifesciences Share price

COVIDH

IT Industry Small Cap

77.49

0.00 (0.00%)

Last updated on 4 May, 2026 | 13:15 IST

BUYSELL

Today's High

77.49

Today's Low

77.49

52 Week Low

1.50

52 Week High

77.49

Free Demat with Zero AMC*

iSERA Lifesciences Chart

ChartIQ

TradingView

iSERA Lifesciences Share Key Metrics

Volume

9431.00

Market Cap

65.16 CR

LTQ@LTP

2000@77.49

ATP

77.49 Var Margin

100 %

Circuit Range

75.95-77.49

Delivery %

100 %

Value

7.31 L

ASM/GSM

No

Market Lot

1

Summary

4 May, 2026 | 13:15 को, iSERA Lifesciences का शेयर प्राइस आज ₹77.49 पर है, जो दिन के लिए 0.00% की 0.00 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹77.49 और ₹77.49 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹1.50 से ₹77.49 तक रही है। ट्रेडिंग गतिविधि के मामले में, iSERA Lifesciences ने 9431 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹8408972 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹7749 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 2000,7749 रही। यह स्टॉक ₹75.95-77.49 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹7.31 L है। दिन के लिए डिलीवरी परसेंटेज 100% रही। इसके अतिरिक्त, iSERA Lifesciences वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

iSERA Lifesciences Fundamentals

P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

142.67

Sector P/B

3.08

Sec. Div. Yield

0.64

iSERA Lifesciences Resistance and Support

Pivot 77.49

Resistance

First Resistance

77.49

Second Resistance

77.49

Third Resistance

77.49

Support

First Support

77.49

Second Support

77.49

Third Support

77.49

iSERA Lifesciences Shareholding Pattern

2016-17
2018-19
2019-20
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

26.35%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

73.65%

Others

0%

Total Promoters

MAR '24

26.35%

JUN '24

26.35%

SEP '24

26.35%

DEC '24

26.35%

iSERA Lifesciences Corporate Actions

Date	Agenda
2026-04-20	Preferential issue of shares
2026-02-10	Quarterly Results

iSERA Lifesciences News

Covidh Technologies Ltd - 534920 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

ISERA Lifesciences seeks shareholder approval for strategic moves, including increasing authorized capital to ₹25 crores and expanding investment limits to ₹1,000 crores. The company also plans to acquire iSERA Biological for ₹78 crores via a share swap to bolster its pharmaceutical and life sciences sector presence.

Apr 21 2026 18:04:00

Covidh Technologies Ltd - 534920 - Revised Outcome Of The Meeting Of The Board Of Directors Of Isera Lifesciences Limited (Formerly Known As Covidh Technologies Limited) ('The Company') Pursuant To Regulation 29 And 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

iSERA Lifesciences board approved the acquisition of 100% equity in iSERA Biological Limited for ₹78.00 crores, to be settled through a share swap. This move aims to expand its presence in pharmaceuticals and life sciences, creating synergistic value for shareholders.

Apr 21 2026 15:04:00

Covidh Technologies Ltd - 534920 - Announcement under Regulation 30 (LODR)-Preferential Issue

iSERA Lifesciences board approved a substantial increase in authorized share capital from ₹11 crore to ₹25 crore. This strategic move facilitates the acquisition of iSERA Biological Limited for ₹78 crore through a share swap, aiming to enhance its pharmaceutical and biotech market presence.

Apr 21 2026 13:04:00

Covidh Technologies Ltd - 534920 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association

iSERA Lifesciences board approved a substantial increase in authorized share capital from ₹11 crore to ₹25 crore. This strategic move facilitates the acquisition of iSERA Biological Limited for ₹78 crore through a share swap, aiming to enhance its pharmaceutical and biotech market presence.

Apr 21 2026 13:04:00

Covidh Technologies Ltd - 534920 - Announcement under Regulation 30 (LODR)-Acquisition

iSERA Lifesciences board approved a substantial increase in authorized share capital from ₹11 crore to ₹25 crore. This strategic move facilitates the acquisition of iSERA Biological Limited for ₹78 crore through a share swap, aiming to enhance its pharmaceutical and biotech market presence.

Apr 21 2026 13:04:00

Covidh Technologies Ltd - 534920 - Announcement under Regulation 30 (LODR)-Raising of Funds

iSERA Lifesciences board approved a substantial increase in authorized share capital from ₹11 crore to ₹25 crore. This strategic move facilitates the acquisition of iSERA Biological Limited for ₹78 crore through a share swap, aiming to enhance its pharmaceutical and biotech market presence.

Apr 21 2026 13:04:00

Covidh Technologies Ltd - 534920 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Isera Lifesciences Limited (Formerly Known As Covidh Technologies Limited) ('The Company')

iSERA Lifesciences board approved a substantial increase in authorized share capital from ₹11 crore to ₹25 crore. This strategic move facilitates the acquisition of iSERA Biological Limited for ₹78 crore through a share swap, aiming to enhance its pharmaceutical and biotech market presence.

Apr 21 2026 13:04:00

Covidh Technologies Ltd - 534920 - Board Meeting Outcome for Intimation Of Deferment Of Board Meeting Of Isera Lifesciences Limited (Formerly Known As Covidh Technologies Limited) Scheduled On Monday, April 20, 2026.

ISERA Lifesciences' board meeting, set for April 20, 2026, has been deferred. The meeting was to consider and approve a preferential issue of equity shares, but additional time is required for procedural and documentation formalities.

Apr 20 2026 16:04:00

Covidh Technologies Ltd - 534920 - Board Meeting Intimation for Prior Intimation Of The Board Meeting Pursuant To Regulation 29(1)(D) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

iSERA Lifesciences board will meet on April 20, 2026, to consider and approve a preferential issue of equity shares. This capital raise will be done through a private placement basis to fund growth.

Apr 15 2026 17:04:00

Covidh Technologies Ltd - 534920 - Announcement under Regulation 30 (LODR)-Change of Company Name

The Ministry of Corporate Affairs (MCA) has approved the name change of the company from 'Covidh Technologies Limited' to 'iSERA Lifesciences Limited'. This change is effective from April 10, 2026, and follows prior approvals from the Board on March 10, 2026, and an EGM on April 02, 2026.

Apr 10 2026 17:04:00

NSE : 0

BSE : 534920

ISIN : INE899M01020

The Company Fastrak Capitals Ltd. was originallyincorporated as private limited company under the name ofAarya Consultants (P) Ltd. on 27-1-93 and subsequentlychanged its name to Fastrak Capitals (P) Ltd. and obtainedcertificate of incorporation on 1-03-96 and subsequentlyconverted into Fastrak Capitals Limited and obtained freshcertificate of incorporation on 8-03-96 from the Registrarof Companies Andhra Pradesh Hyderabad. The Company hasstarted Commercial operations from 28-01-93. The Companyhas also been in the field of Project Consultancy andInvestment Consultancy. Being promoted by experiencedprofessional and armed with good professionals on theemployment rolls who have got good experience in thefinance and allied fields and further being equipped withgood information system and procedures and its own equityresearch division it was able to establish itself in theline of Investments Investment consultancy and ProjectConsultancy. The Company has developed wide contacts goodnetwork and poised to take-up other activities of MerchantBanking leasing and Hire-purchase.

Name	Position
Jayshree Suresh	Managing Director
Jitendra Prabhakar Nene	Executive Director

iSERA Lifesciences Similar Stocks

Cranes Software International Ltd.

3.54

-0.09 (2.48%)

Riddhi Corporate Services Ltd.

57.60

-0.24 (0.41%)

HandsOn Global Management (HGM) Ltd.

56.60

2.62 (4.85%)

Cambridge Technology Enterprises Ltd.

34.39

0.89 (2.66%)

Jupiter Infomedia Ltd.

63.69

-0.17 (0.27%)

LCC Infotech Ltd.

4.67

-0.21 (4.30%)

Starcom Information Technology Ltd.

46.51

-1.65 (3.43%)

Suvidhaa Infoserve Ltd.

2.95

0.08 (2.79%)

iSERA Lifesciences FAQs

iSERA Lifesciences शेयर का खरीद मूल्य 77.49 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

iSERA Lifesciences शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

iSERA Lifesciences शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 0 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

iSERA Lifesciences शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 0 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

iSERA Lifesciences शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.08 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

iSERA Lifesciences का मार्केट कैप 65.16 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

iSERA Lifesciences शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 77.49 और 1.50 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

Open Account Now